Article ISI SCOPUS
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY  (2017)

Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease

Más información

Título según WOS: Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease
Título según SCOPUS: Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease
Título de la Revista: CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Editorial: HINDAWI LTD
Fecha de publicación: 2017
Idioma: English
DOI:

10.1155/2017/7365937
Notas: ISI, SCOPUS